CIK: 0001844645 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 11, 2023
Total Value ($000): $303,345 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS INC | 782,008 | $169,578 | 55.9% | $104.04 | — | COM | 48576A100 |
| PCVX | VAXCYTE INC | 793,036 | $39,604 | 13.1% | $38.47 | +23.2% | COM | 92243G108 |
| OCS | OCULIS HOLDING AG | 2,381,196 | $29,360 | 9.7% | $9.59 | +16.3% | ORDINARY SHARES | H5870P102 |
| — | INOZYME PHARMA INC | 3,661,518 | $20,395 | 6.7% | $11.91 | — | COM | 45790W108 |
| — | RALLYBIO CORP | 2,404,644 | $13,610 | 4.5% | $16.97 | — | COM | 75120L100 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,105,309 | $10,534 | 3.5% | $18.00 | -38.3% | COM | 03969K108 |
| — | FUSION PHARMACEUTICALS INC | 1,560,982 | $7,290 | 2.4% | $11.75 | — | COM | 36118A100 |
| — | VIGIL NEUROSCIENCE INC | 560,595 | $5,270 | 1.7% | $7.03 | — | COM | 92673K108 |
| — | EXSCIENTIA PLC | 770,500 | $4,561 | 1.5% | $19.76 | — | ADS | 30223G102 |
| — | BOLT BIOTHERAPEUTICS INC | 1,891,467 | $2,421 | 0.8% | $32.91 | — | COM | 097702104 |
| — | ALIGOS THERAPEUTICS INC | 743,215 | $722 | 0.2% | $27.65 | — | COM | 01626L105 |